These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 19606064)
21. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice. Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401 [TBL] [Abstract][Full Text] [Related]
22. Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene. Capellari S; Cardone F; Notari S; Schininà ME; Maras B; Sità D; Baruzzi A; Pocchiari M; Parchi P Neurology; 2005 Mar; 64(5):905-7. PubMed ID: 15753435 [TBL] [Abstract][Full Text] [Related]
23. Complement factors C1q and C3b in brains with Creutzfeldt-Jakob disease. Nawrocka-Kunecka A; Papierz W; Liberski PP Pol J Pathol; 2005; 56(3):127-9. PubMed ID: 16334980 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease. Iwasaki Y; Mimuro M; Yoshida M; Hashizume Y; Kitamoto T; Sobue G Neuropathology; 2008 Feb; 28(1):51-61. PubMed ID: 18181835 [TBL] [Abstract][Full Text] [Related]
26. Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease. Ferrer I Cerebellum; 2002 Jul; 1(3):213-22. PubMed ID: 12879983 [TBL] [Abstract][Full Text] [Related]
27. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895 [TBL] [Abstract][Full Text] [Related]
28. Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies. Fraser E; McDonagh AM; Head M; Bishop M; Ironside JW; Mann DM Neuropathol Appl Neurobiol; 2003 Oct; 29(5):482-95. PubMed ID: 14507340 [TBL] [Abstract][Full Text] [Related]
29. [Recent advances in the research of Creutzfeldt-Jakob disease (CJD) and Gerstmann-Strüssler syndrome (GSS)]. Tateishi J Rinsho Shinkeigaku; 1991 Dec; 31(12):1306-8. PubMed ID: 1687809 [TBL] [Abstract][Full Text] [Related]
30. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases. Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818 [TBL] [Abstract][Full Text] [Related]
31. Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease. Van Everbroeck B; Dobbeleir I; De Waele M; De Leenheir E; Lübke U; Martin JJ; Cras P Acta Neuropathol; 2004 Sep; 108(3):194-200. PubMed ID: 15221335 [TBL] [Abstract][Full Text] [Related]
33. Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases. Kovacs GG; Voigtländer T; Hainfellner JA; Budka H Acta Neuropathol; 2002 Sep; 104(3):320-6. PubMed ID: 12172919 [TBL] [Abstract][Full Text] [Related]
35. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221 [TBL] [Abstract][Full Text] [Related]
36. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. Hizume M; Kobayashi A; Teruya K; Ohashi H; Ironside JW; Mohri S; Kitamoto T J Biol Chem; 2009 Feb; 284(6):3603-9. PubMed ID: 19074151 [TBL] [Abstract][Full Text] [Related]
37. [PRP(CJD) reproduction in the cerebral vascular plexus epitheliocytes in a new type of Creutzfeldt-Jakob disease]. Karmysheva VIa; Pogodina VV Arkh Patol; 2007; 69(5):28-31. PubMed ID: 18074816 [TBL] [Abstract][Full Text] [Related]
38. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Cronier S; Laude H; Peyrin JM Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929 [TBL] [Abstract][Full Text] [Related]
39. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Mitrová E; Belay G Acta Virol; 2002; 46(1):31-9. PubMed ID: 12197632 [TBL] [Abstract][Full Text] [Related]
40. Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease. Iwasaki Y; Yoshida M; Hashizume Y; Kitamoto T; Sobue G Acta Neuropathol; 2005 Nov; 110(5):490-500. PubMed ID: 16175355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]